nodes	percent_of_prediction	percent_of_DWPC	metapath
Dextropropoxyphene—CYP3A7—Vincristine—sarcoma	0.144	0.196	CbGbCtD
Dextropropoxyphene—CYP3A7-CYP3A51P—Vincristine—sarcoma	0.144	0.196	CbGbCtD
Dextropropoxyphene—CYP3A4—Thiotepa—sarcoma	0.142	0.194	CbGbCtD
Dextropropoxyphene—CYP2C8—Etoposide—sarcoma	0.0952	0.129	CbGbCtD
Dextropropoxyphene—CYP3A4—Mitoxantrone—sarcoma	0.0612	0.0833	CbGbCtD
Dextropropoxyphene—CYP3A4—Vincristine—sarcoma	0.0421	0.0573	CbGbCtD
Dextropropoxyphene—CYP2D6—Doxorubicin—sarcoma	0.0414	0.0563	CbGbCtD
Dextropropoxyphene—CYP3A4—Etoposide—sarcoma	0.0386	0.0525	CbGbCtD
Dextropropoxyphene—CYP3A4—Doxorubicin—sarcoma	0.0263	0.0358	CbGbCtD
Dextropropoxyphene—Respiratory arrest—Thiotepa—sarcoma	0.00868	0.0328	CcSEcCtD
Dextropropoxyphene—Metabolic acidosis—Etoposide—sarcoma	0.00694	0.0263	CcSEcCtD
Dextropropoxyphene—Hepatomegaly—Thiotepa—sarcoma	0.0054	0.0204	CcSEcCtD
Dextropropoxyphene—Hepatomegaly—Dactinomycin—sarcoma	0.00536	0.0203	CcSEcCtD
Dextropropoxyphene—Drug interaction—Vincristine—sarcoma	0.00365	0.0138	CcSEcCtD
Dextropropoxyphene—Coma—Vincristine—sarcoma	0.00309	0.0117	CcSEcCtD
Dextropropoxyphene—Cardiac failure congestive—Mitoxantrone—sarcoma	0.00264	0.00999	CcSEcCtD
Dextropropoxyphene—Cardiac arrest—Thiotepa—sarcoma	0.00264	0.00997	CcSEcCtD
Dextropropoxyphene—Ataxia—Thiotepa—sarcoma	0.00261	0.00986	CcSEcCtD
Dextropropoxyphene—Liver function test abnormal—Dactinomycin—sarcoma	0.00254	0.00961	CcSEcCtD
Dextropropoxyphene—Gastrointestinal haemorrhage—Mitoxantrone—sarcoma	0.00239	0.00906	CcSEcCtD
Dextropropoxyphene—Cardiac arrest—Vincristine—sarcoma	0.00234	0.00884	CcSEcCtD
Dextropropoxyphene—Ataxia—Vincristine—sarcoma	0.00231	0.00874	CcSEcCtD
Dextropropoxyphene—Cardiac failure congestive—Etoposide—sarcoma	0.0022	0.00831	CcSEcCtD
Dextropropoxyphene—Hepatomegaly—Epirubicin—sarcoma	0.00217	0.00822	CcSEcCtD
Dextropropoxyphene—Jaundice—Thiotepa—sarcoma	0.00208	0.00788	CcSEcCtD
Dextropropoxyphene—Hepatobiliary disease—Thiotepa—sarcoma	0.00202	0.00764	CcSEcCtD
Dextropropoxyphene—Hepatomegaly—Doxorubicin—sarcoma	0.00201	0.0076	CcSEcCtD
Dextropropoxyphene—Hallucination—Thiotepa—sarcoma	0.00191	0.00722	CcSEcCtD
Dextropropoxyphene—Cardiac arrest—Etoposide—sarcoma	0.00189	0.00716	CcSEcCtD
Dextropropoxyphene—Acute coronary syndrome—Vincristine—sarcoma	0.00187	0.00706	CcSEcCtD
Dextropropoxyphene—Myocardial infarction—Vincristine—sarcoma	0.00186	0.00702	CcSEcCtD
Dextropropoxyphene—Drowsiness—Mitoxantrone—sarcoma	0.00184	0.00698	CcSEcCtD
Dextropropoxyphene—Liver injury—Epirubicin—sarcoma	0.00183	0.00691	CcSEcCtD
Dextropropoxyphene—Acute coronary syndrome—Mitoxantrone—sarcoma	0.00182	0.00688	CcSEcCtD
Dextropropoxyphene—Myocardial infarction—Mitoxantrone—sarcoma	0.00181	0.00684	CcSEcCtD
Dextropropoxyphene—Jaundice—Mitoxantrone—sarcoma	0.0018	0.0068	CcSEcCtD
Dextropropoxyphene—Eye disorder—Thiotepa—sarcoma	0.00179	0.00678	CcSEcCtD
Dextropropoxyphene—Cardiac disorder—Thiotepa—sarcoma	0.00178	0.00673	CcSEcCtD
Dextropropoxyphene—Jaundice cholestatic—Epirubicin—sarcoma	0.00175	0.00662	CcSEcCtD
Dextropropoxyphene—Immune system disorder—Thiotepa—sarcoma	0.00173	0.00655	CcSEcCtD
Dextropropoxyphene—Mediastinal disorder—Thiotepa—sarcoma	0.00173	0.00654	CcSEcCtD
Dextropropoxyphene—Arrhythmia—Thiotepa—sarcoma	0.00171	0.00648	CcSEcCtD
Dextropropoxyphene—Hallucination—Vincristine—sarcoma	0.00169	0.0064	CcSEcCtD
Dextropropoxyphene—Liver injury—Doxorubicin—sarcoma	0.00169	0.0064	CcSEcCtD
Dextropropoxyphene—Bradycardia—Mitoxantrone—sarcoma	0.00169	0.00638	CcSEcCtD
Dextropropoxyphene—Malnutrition—Thiotepa—sarcoma	0.00167	0.00632	CcSEcCtD
Dextropropoxyphene—Jaundice cholestatic—Doxorubicin—sarcoma	0.00162	0.00613	CcSEcCtD
Dextropropoxyphene—Cardiac disorder—Vincristine—sarcoma	0.00158	0.00597	CcSEcCtD
Dextropropoxyphene—Vision blurred—Thiotepa—sarcoma	0.00157	0.00595	CcSEcCtD
Dextropropoxyphene—Hepatocellular injury—Epirubicin—sarcoma	0.00154	0.00582	CcSEcCtD
Dextropropoxyphene—Agitation—Thiotepa—sarcoma	0.00153	0.0058	CcSEcCtD
Dextropropoxyphene—Mediastinal disorder—Vincristine—sarcoma	0.00153	0.0058	CcSEcCtD
Dextropropoxyphene—Acute coronary syndrome—Etoposide—sarcoma	0.00151	0.00572	CcSEcCtD
Dextropropoxyphene—Myocardial infarction—Etoposide—sarcoma	0.0015	0.00569	CcSEcCtD
Dextropropoxyphene—Jaundice—Etoposide—sarcoma	0.0015	0.00566	CcSEcCtD
Dextropropoxyphene—Arrhythmia—Mitoxantrone—sarcoma	0.00148	0.0056	CcSEcCtD
Dextropropoxyphene—Hepatobiliary disease—Etoposide—sarcoma	0.00145	0.00549	CcSEcCtD
Dextropropoxyphene—Convulsion—Thiotepa—sarcoma	0.00145	0.00547	CcSEcCtD
Dextropropoxyphene—Hepatocellular injury—Doxorubicin—sarcoma	0.00142	0.00538	CcSEcCtD
Dextropropoxyphene—Coma—Epirubicin—sarcoma	0.00141	0.00532	CcSEcCtD
Dextropropoxyphene—Discomfort—Dactinomycin—sarcoma	0.00139	0.00527	CcSEcCtD
Dextropropoxyphene—Confusional state—Thiotepa—sarcoma	0.00137	0.0052	CcSEcCtD
Dextropropoxyphene—Agitation—Vincristine—sarcoma	0.00136	0.00515	CcSEcCtD
Dextropropoxyphene—Vision blurred—Mitoxantrone—sarcoma	0.00136	0.00514	CcSEcCtD
Dextropropoxyphene—Nervous system disorder—Thiotepa—sarcoma	0.00134	0.00505	CcSEcCtD
Dextropropoxyphene—Tachycardia—Thiotepa—sarcoma	0.00133	0.00503	CcSEcCtD
Dextropropoxyphene—Coma—Doxorubicin—sarcoma	0.0013	0.00492	CcSEcCtD
Dextropropoxyphene—Eye disorder—Etoposide—sarcoma	0.00129	0.00487	CcSEcCtD
Dextropropoxyphene—Convulsion—Vincristine—sarcoma	0.00128	0.00485	CcSEcCtD
Dextropropoxyphene—Cardiac disorder—Etoposide—sarcoma	0.00128	0.00484	CcSEcCtD
Dextropropoxyphene—Hepatic function abnormal—Epirubicin—sarcoma	0.00128	0.00483	CcSEcCtD
Dextropropoxyphene—Convulsion—Mitoxantrone—sarcoma	0.00125	0.00473	CcSEcCtD
Dextropropoxyphene—Immune system disorder—Etoposide—sarcoma	0.00124	0.00471	CcSEcCtD
Dextropropoxyphene—Mediastinal disorder—Etoposide—sarcoma	0.00124	0.0047	CcSEcCtD
Dextropropoxyphene—Cardiac failure congestive—Epirubicin—sarcoma	0.00123	0.00466	CcSEcCtD
Dextropropoxyphene—Discomfort—Mitoxantrone—sarcoma	0.00121	0.00459	CcSEcCtD
Dextropropoxyphene—Somnolence—Thiotepa—sarcoma	0.00121	0.00458	CcSEcCtD
Dextropropoxyphene—Dyspepsia—Thiotepa—sarcoma	0.0012	0.00454	CcSEcCtD
Dextropropoxyphene—Confusional state—Mitoxantrone—sarcoma	0.00119	0.00449	CcSEcCtD
Dextropropoxyphene—Nervous system disorder—Vincristine—sarcoma	0.00118	0.00448	CcSEcCtD
Dextropropoxyphene—Hepatic function abnormal—Doxorubicin—sarcoma	0.00118	0.00447	CcSEcCtD
Dextropropoxyphene—Gastrointestinal disorder—Thiotepa—sarcoma	0.00118	0.00445	CcSEcCtD
Dextropropoxyphene—Constipation—Thiotepa—sarcoma	0.00117	0.00441	CcSEcCtD
Dextropropoxyphene—Shock—Mitoxantrone—sarcoma	0.00116	0.00438	CcSEcCtD
Dextropropoxyphene—Tachycardia—Mitoxantrone—sarcoma	0.00115	0.00434	CcSEcCtD
Dextropropoxyphene—Cardiac failure congestive—Doxorubicin—sarcoma	0.00114	0.00431	CcSEcCtD
Dextropropoxyphene—Hypotension—Vincristine—sarcoma	0.00113	0.00427	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Thiotepa—sarcoma	0.00112	0.00425	CcSEcCtD
Dextropropoxyphene—Gastrointestinal haemorrhage—Epirubicin—sarcoma	0.00112	0.00422	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Dactinomycin—sarcoma	0.00111	0.00422	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Thiotepa—sarcoma	0.00111	0.00421	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Dactinomycin—sarcoma	0.00111	0.00418	CcSEcCtD
Dextropropoxyphene—Hypotension—Mitoxantrone—sarcoma	0.0011	0.00416	CcSEcCtD
Dextropropoxyphene—Insomnia—Vincristine—sarcoma	0.00109	0.00413	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Thiotepa—sarcoma	0.00108	0.00407	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Dactinomycin—sarcoma	0.00107	0.00404	CcSEcCtD
Dextropropoxyphene—Cardiac arrest—Epirubicin—sarcoma	0.00106	0.00402	CcSEcCtD
Dextropropoxyphene—Loss of consciousness—Etoposide—sarcoma	0.00105	0.00399	CcSEcCtD
Dextropropoxyphene—Ataxia—Epirubicin—sarcoma	0.00105	0.00397	CcSEcCtD
Dextropropoxyphene—Dyspnoea—Mitoxantrone—sarcoma	0.00105	0.00397	CcSEcCtD
Dextropropoxyphene—Somnolence—Mitoxantrone—sarcoma	0.00105	0.00396	CcSEcCtD
Dextropropoxyphene—Gastrointestinal disorder—Vincristine—sarcoma	0.00104	0.00395	CcSEcCtD
Dextropropoxyphene—Convulsion—Etoposide—sarcoma	0.00104	0.00393	CcSEcCtD
Dextropropoxyphene—Dyspepsia—Mitoxantrone—sarcoma	0.00104	0.00392	CcSEcCtD
Dextropropoxyphene—Constipation—Vincristine—sarcoma	0.00103	0.00391	CcSEcCtD
Dextropropoxyphene—Gastrointestinal haemorrhage—Doxorubicin—sarcoma	0.00103	0.00391	CcSEcCtD
Dextropropoxyphene—Liver function test abnormal—Epirubicin—sarcoma	0.00103	0.0039	CcSEcCtD
Dextropropoxyphene—Discomfort—Etoposide—sarcoma	0.00101	0.00382	CcSEcCtD
Dextropropoxyphene—Constipation—Mitoxantrone—sarcoma	0.00101	0.00381	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Thiotepa—sarcoma	0.001	0.0038	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Dactinomycin—sarcoma	0.000996	0.00377	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Vincristine—sarcoma	0.000988	0.00374	CcSEcCtD
Dextropropoxyphene—Confusional state—Etoposide—sarcoma	0.000987	0.00373	CcSEcCtD
Dextropropoxyphene—Cardiac arrest—Doxorubicin—sarcoma	0.000982	0.00372	CcSEcCtD
Dextropropoxyphene—Asthenia—Thiotepa—sarcoma	0.000978	0.0037	CcSEcCtD
Dextropropoxyphene—Ataxia—Doxorubicin—sarcoma	0.000971	0.00367	CcSEcCtD
Dextropropoxyphene—Asthenia—Dactinomycin—sarcoma	0.00097	0.00367	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Mitoxantrone—sarcoma	0.00097	0.00367	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Mitoxantrone—sarcoma	0.000962	0.00364	CcSEcCtD
Dextropropoxyphene—Tachycardia—Etoposide—sarcoma	0.000955	0.00361	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Vincristine—sarcoma	0.000955	0.00361	CcSEcCtD
Dextropropoxyphene—Liver function test abnormal—Doxorubicin—sarcoma	0.000954	0.00361	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Thiotepa—sarcoma	0.000932	0.00353	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Mitoxantrone—sarcoma	0.00093	0.00352	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Dactinomycin—sarcoma	0.000925	0.0035	CcSEcCtD
Dextropropoxyphene—Hypotension—Etoposide—sarcoma	0.000915	0.00346	CcSEcCtD
Dextropropoxyphene—Dizziness—Thiotepa—sarcoma	0.000901	0.00341	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Vincristine—sarcoma	0.00089	0.00337	CcSEcCtD
Dextropropoxyphene—Dyspnoea—Etoposide—sarcoma	0.000873	0.0033	CcSEcCtD
Dextropropoxyphene—Somnolence—Etoposide—sarcoma	0.00087	0.00329	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Mitoxantrone—sarcoma	0.000867	0.00328	CcSEcCtD
Dextropropoxyphene—Asthenia—Vincristine—sarcoma	0.000867	0.00328	CcSEcCtD
Dextropropoxyphene—Vomiting—Thiotepa—sarcoma	0.000866	0.00328	CcSEcCtD
Dextropropoxyphene—Drowsiness—Epirubicin—sarcoma	0.00086	0.00325	CcSEcCtD
Dextropropoxyphene—Vomiting—Dactinomycin—sarcoma	0.00086	0.00325	CcSEcCtD
Dextropropoxyphene—Rash—Thiotepa—sarcoma	0.000859	0.00325	CcSEcCtD
Dextropropoxyphene—Dermatitis—Thiotepa—sarcoma	0.000858	0.00325	CcSEcCtD
Dextropropoxyphene—Headache—Thiotepa—sarcoma	0.000854	0.00323	CcSEcCtD
Dextropropoxyphene—Rash—Dactinomycin—sarcoma	0.000853	0.00323	CcSEcCtD
Dextropropoxyphene—Gastrointestinal disorder—Etoposide—sarcoma	0.000845	0.0032	CcSEcCtD
Dextropropoxyphene—Asthenia—Mitoxantrone—sarcoma	0.000844	0.00319	CcSEcCtD
Dextropropoxyphene—Jaundice—Epirubicin—sarcoma	0.000839	0.00317	CcSEcCtD
Dextropropoxyphene—Constipation—Etoposide—sarcoma	0.000837	0.00317	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Vincristine—sarcoma	0.000827	0.00313	CcSEcCtD
Dextropropoxyphene—Hepatobiliary disease—Epirubicin—sarcoma	0.000814	0.00308	CcSEcCtD
Dextropropoxyphene—Nausea—Thiotepa—sarcoma	0.000809	0.00306	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Etoposide—sarcoma	0.000807	0.00305	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Mitoxantrone—sarcoma	0.000805	0.00305	CcSEcCtD
Dextropropoxyphene—Nausea—Dactinomycin—sarcoma	0.000803	0.00304	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Etoposide—sarcoma	0.0008	0.00303	CcSEcCtD
Dextropropoxyphene—Dizziness—Vincristine—sarcoma	0.000799	0.00302	CcSEcCtD
Dextropropoxyphene—Drowsiness—Doxorubicin—sarcoma	0.000796	0.00301	CcSEcCtD
Dextropropoxyphene—Bradycardia—Epirubicin—sarcoma	0.000786	0.00297	CcSEcCtD
Dextropropoxyphene—Jaundice—Doxorubicin—sarcoma	0.000776	0.00293	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Etoposide—sarcoma	0.000774	0.00293	CcSEcCtD
Dextropropoxyphene—Vomiting—Vincristine—sarcoma	0.000768	0.00291	CcSEcCtD
Dextropropoxyphene—Rash—Vincristine—sarcoma	0.000762	0.00288	CcSEcCtD
Dextropropoxyphene—Dermatitis—Vincristine—sarcoma	0.000761	0.00288	CcSEcCtD
Dextropropoxyphene—Headache—Vincristine—sarcoma	0.000757	0.00286	CcSEcCtD
Dextropropoxyphene—Hepatobiliary disease—Doxorubicin—sarcoma	0.000753	0.00285	CcSEcCtD
Dextropropoxyphene—Vomiting—Mitoxantrone—sarcoma	0.000748	0.00283	CcSEcCtD
Dextropropoxyphene—Visual impairment—Epirubicin—sarcoma	0.000744	0.00282	CcSEcCtD
Dextropropoxyphene—Rash—Mitoxantrone—sarcoma	0.000742	0.00281	CcSEcCtD
Dextropropoxyphene—Dermatitis—Mitoxantrone—sarcoma	0.000741	0.0028	CcSEcCtD
Dextropropoxyphene—Headache—Mitoxantrone—sarcoma	0.000737	0.00279	CcSEcCtD
Dextropropoxyphene—Bradycardia—Doxorubicin—sarcoma	0.000727	0.00275	CcSEcCtD
Dextropropoxyphene—Eye disorder—Epirubicin—sarcoma	0.000722	0.00273	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Etoposide—sarcoma	0.000721	0.00273	CcSEcCtD
Dextropropoxyphene—Nausea—Vincristine—sarcoma	0.000718	0.00271	CcSEcCtD
Dextropropoxyphene—Cardiac disorder—Epirubicin—sarcoma	0.000717	0.00271	CcSEcCtD
Dextropropoxyphene—Asthenia—Etoposide—sarcoma	0.000702	0.00266	CcSEcCtD
Dextropropoxyphene—Nausea—Mitoxantrone—sarcoma	0.000699	0.00264	CcSEcCtD
Dextropropoxyphene—Immune system disorder—Epirubicin—sarcoma	0.000698	0.00264	CcSEcCtD
Dextropropoxyphene—Mediastinal disorder—Epirubicin—sarcoma	0.000696	0.00263	CcSEcCtD
Dextropropoxyphene—Arrhythmia—Epirubicin—sarcoma	0.00069	0.00261	CcSEcCtD
Dextropropoxyphene—Visual impairment—Doxorubicin—sarcoma	0.000689	0.0026	CcSEcCtD
Dextropropoxyphene—Malnutrition—Epirubicin—sarcoma	0.000672	0.00254	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Etoposide—sarcoma	0.00067	0.00253	CcSEcCtD
Dextropropoxyphene—Eye disorder—Doxorubicin—sarcoma	0.000668	0.00253	CcSEcCtD
Dextropropoxyphene—Cardiac disorder—Doxorubicin—sarcoma	0.000663	0.00251	CcSEcCtD
Dextropropoxyphene—Dizziness—Etoposide—sarcoma	0.000647	0.00245	CcSEcCtD
Dextropropoxyphene—Immune system disorder—Doxorubicin—sarcoma	0.000645	0.00244	CcSEcCtD
Dextropropoxyphene—Mediastinal disorder—Doxorubicin—sarcoma	0.000644	0.00244	CcSEcCtD
Dextropropoxyphene—Arrhythmia—Doxorubicin—sarcoma	0.000638	0.00241	CcSEcCtD
Dextropropoxyphene—Vision blurred—Epirubicin—sarcoma	0.000634	0.0024	CcSEcCtD
Dextropropoxyphene—Vomiting—Etoposide—sarcoma	0.000622	0.00235	CcSEcCtD
Dextropropoxyphene—Malnutrition—Doxorubicin—sarcoma	0.000622	0.00235	CcSEcCtD
Dextropropoxyphene—Agitation—Epirubicin—sarcoma	0.000618	0.00234	CcSEcCtD
Dextropropoxyphene—Rash—Etoposide—sarcoma	0.000617	0.00233	CcSEcCtD
Dextropropoxyphene—Dermatitis—Etoposide—sarcoma	0.000617	0.00233	CcSEcCtD
Dextropropoxyphene—Headache—Etoposide—sarcoma	0.000613	0.00232	CcSEcCtD
Dextropropoxyphene—Syncope—Epirubicin—sarcoma	0.000603	0.00228	CcSEcCtD
Dextropropoxyphene—Loss of consciousness—Epirubicin—sarcoma	0.000591	0.00224	CcSEcCtD
Dextropropoxyphene—Vision blurred—Doxorubicin—sarcoma	0.000586	0.00222	CcSEcCtD
Dextropropoxyphene—Convulsion—Epirubicin—sarcoma	0.000582	0.0022	CcSEcCtD
Dextropropoxyphene—Nausea—Etoposide—sarcoma	0.000581	0.0022	CcSEcCtD
Dextropropoxyphene—Agitation—Doxorubicin—sarcoma	0.000572	0.00216	CcSEcCtD
Dextropropoxyphene—Discomfort—Epirubicin—sarcoma	0.000565	0.00214	CcSEcCtD
Dextropropoxyphene—Syncope—Doxorubicin—sarcoma	0.000558	0.00211	CcSEcCtD
Dextropropoxyphene—Confusional state—Epirubicin—sarcoma	0.000553	0.00209	CcSEcCtD
Dextropropoxyphene—Loss of consciousness—Doxorubicin—sarcoma	0.000547	0.00207	CcSEcCtD
Dextropropoxyphene—Shock—Epirubicin—sarcoma	0.00054	0.00204	CcSEcCtD
Dextropropoxyphene—Convulsion—Doxorubicin—sarcoma	0.000539	0.00204	CcSEcCtD
Dextropropoxyphene—Nervous system disorder—Epirubicin—sarcoma	0.000538	0.00204	CcSEcCtD
Dextropropoxyphene—Tachycardia—Epirubicin—sarcoma	0.000535	0.00203	CcSEcCtD
Dextropropoxyphene—Discomfort—Doxorubicin—sarcoma	0.000523	0.00198	CcSEcCtD
Dextropropoxyphene—Hypotension—Epirubicin—sarcoma	0.000513	0.00194	CcSEcCtD
Dextropropoxyphene—Confusional state—Doxorubicin—sarcoma	0.000512	0.00194	CcSEcCtD
Dextropropoxyphene—Shock—Doxorubicin—sarcoma	0.000499	0.00189	CcSEcCtD
Dextropropoxyphene—Nervous system disorder—Doxorubicin—sarcoma	0.000498	0.00188	CcSEcCtD
Dextropropoxyphene—Insomnia—Epirubicin—sarcoma	0.000496	0.00188	CcSEcCtD
Dextropropoxyphene—Tachycardia—Doxorubicin—sarcoma	0.000495	0.00187	CcSEcCtD
Dextropropoxyphene—Dyspnoea—Epirubicin—sarcoma	0.000489	0.00185	CcSEcCtD
Dextropropoxyphene—Somnolence—Epirubicin—sarcoma	0.000488	0.00185	CcSEcCtD
Dextropropoxyphene—Dyspepsia—Epirubicin—sarcoma	0.000483	0.00183	CcSEcCtD
Dextropropoxyphene—Hypotension—Doxorubicin—sarcoma	0.000474	0.00179	CcSEcCtD
Dextropropoxyphene—Gastrointestinal disorder—Epirubicin—sarcoma	0.000474	0.00179	CcSEcCtD
Dextropropoxyphene—Constipation—Epirubicin—sarcoma	0.000469	0.00177	CcSEcCtD
Dextropropoxyphene—Insomnia—Doxorubicin—sarcoma	0.000459	0.00174	CcSEcCtD
Dextropropoxyphene—Dyspnoea—Doxorubicin—sarcoma	0.000453	0.00171	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Epirubicin—sarcoma	0.000452	0.00171	CcSEcCtD
Dextropropoxyphene—Somnolence—Doxorubicin—sarcoma	0.000451	0.00171	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Epirubicin—sarcoma	0.000449	0.0017	CcSEcCtD
Dextropropoxyphene—Dyspepsia—Doxorubicin—sarcoma	0.000447	0.00169	CcSEcCtD
Dextropropoxyphene—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000438	0.00166	CcSEcCtD
Dextropropoxyphene—Constipation—Doxorubicin—sarcoma	0.000434	0.00164	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Epirubicin—sarcoma	0.000434	0.00164	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Doxorubicin—sarcoma	0.000418	0.00158	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Doxorubicin—sarcoma	0.000415	0.00157	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Epirubicin—sarcoma	0.000404	0.00153	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Doxorubicin—sarcoma	0.000401	0.00152	CcSEcCtD
Dextropropoxyphene—Asthenia—Epirubicin—sarcoma	0.000394	0.00149	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Epirubicin—sarcoma	0.000375	0.00142	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Doxorubicin—sarcoma	0.000374	0.00141	CcSEcCtD
Dextropropoxyphene—Asthenia—Doxorubicin—sarcoma	0.000364	0.00138	CcSEcCtD
Dextropropoxyphene—Dizziness—Epirubicin—sarcoma	0.000363	0.00137	CcSEcCtD
Dextropropoxyphene—Vomiting—Epirubicin—sarcoma	0.000349	0.00132	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Doxorubicin—sarcoma	0.000347	0.00131	CcSEcCtD
Dextropropoxyphene—Rash—Epirubicin—sarcoma	0.000346	0.00131	CcSEcCtD
Dextropropoxyphene—Dermatitis—Epirubicin—sarcoma	0.000346	0.00131	CcSEcCtD
Dextropropoxyphene—Headache—Epirubicin—sarcoma	0.000344	0.0013	CcSEcCtD
Dextropropoxyphene—Dizziness—Doxorubicin—sarcoma	0.000336	0.00127	CcSEcCtD
Dextropropoxyphene—Nausea—Epirubicin—sarcoma	0.000326	0.00123	CcSEcCtD
Dextropropoxyphene—Vomiting—Doxorubicin—sarcoma	0.000323	0.00122	CcSEcCtD
Dextropropoxyphene—Rash—Doxorubicin—sarcoma	0.00032	0.00121	CcSEcCtD
Dextropropoxyphene—Dermatitis—Doxorubicin—sarcoma	0.00032	0.00121	CcSEcCtD
Dextropropoxyphene—Headache—Doxorubicin—sarcoma	0.000318	0.0012	CcSEcCtD
Dextropropoxyphene—Nausea—Doxorubicin—sarcoma	0.000302	0.00114	CcSEcCtD
